SCHEMBL8897798

SCHEMBL8897798

c1ccc(-c2ccc3ncnc(N(c4ccccc4)c4ccccc4)c3c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.58
CYP1A2 P05177 11/20 0.57
CYP3A4 P08684 11/20 0.57
CLK4 Q9HAZ1 9/20 0.57
LMNA P02545 8/20 0.57
ALDH1A1 P00352 8/20 0.57
MAPK1 P28482 7/20 0.57
HSD17B10 Q99714 3/20 0.57
MEN1 O00255 2/20 0.57
CASP1 P29466 2/20 0.57
KMT2A Q03164 2/20 0.57
TP53 P04637 1/20 0.57
CASP7 P55210 1/20 0.57
CYP2D6 P10635 7/20 0.51
CYP2C9 P11712 3/20 0.51
HIF1A Q16665 3/20 0.51
CYP2C19 P33261 6/20 0.50
TSHR P16473 6/20 0.50
CSF1R P07333 4/20 0.50
EGFR P00533 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8900055 0.80 EGFR (0.69) MAP4K4CLK4TSHRCSF1REGFR
Hydrochloric Acid SCHEMBL6039704 0.78 EGFR (0.67) MAP4K4CLK4LMNAMAPK1TSHR
SCHEMBL4353946 0.77 CSF1R (0.80) CYP1A2CYP3A4CLK4LMNAALDH1A1
SCHEMBL4353191 0.77 EGFR (0.64) MAP4K4CYP1A2CYP3A4CLK4LMNA
SCHEMBL28054982 0.75 PIK3CA (0.70) MAP4K4CYP1A2CYP3A4LMNAMAPK1
SCHEMBL30395607 0.75 CSF1R (0.55) MAP4K4CYP1A2CYP3A4CLK4LMNA
SCHEMBL29058819 0.75 CSF1R (0.55) MAP4K4CYP1A2CYP3A4CLK4LMNA
SCHEMBL14189293 0.73 MAP4K4 (0.65) MAP4K4CYP1A2CYP3A4CLK4LMNA
SCHEMBL15587451 0.73 MAP4K4 (1.00) MAP4K4
Hydrochloric Acid SCHEMBL8808017 0.72 EGFR (0.61) CYP1A2CYP3A4CLK4LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO claimed
WO-1997020822-A1 QUINAZOLIN-2,4-DIAZIRINES AS NPY RECEPTOR ANTAGONIST NOVARTIS AG (CH) 1997-06-12 WO disclosed